Acute exacerbations of chronic obstructive pulmonary disease;Exacerbations de bronchopneumopathie chronique obstructive

Presse Medicale

Volumn 38, Issue 3, 2009, Pages 485-495

  Chabot, François ^a   Gomez, Emmanuel ^a   Guillaumot, Anne ^a   Kheir, Ayman ^a   Chaouat, Ari ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTITUSSIVE AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; MUCOLYTIC AGENT; PREDNISONE;

ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COUGHING; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FORCED EXPIRATORY VOLUME; HUMAN; KINESIOTHERAPY; OXYGEN THERAPY; QUALITY OF LIFE; SHORT SURVEY; SPUTUM; SUPPURATION;

ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; BRONCHODILATOR AGENTS; COUGH; DISEASE PROGRESSION; DYSPNEA; HUMANS; INCIDENCE; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM;

EID: 60649115813     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.12.014     Document Type: Short Survey

References (45)

1. Anthonisen N.R., Manfreda J., Warren C.P., Hershfield E.S., Harding G.K., and Nelson N.A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106 (1987) 196-204
2. Recommandations pour la prise en charge de la BPCO. Exacerbations/décompensations : diagnostic, niveaux de gravité et prise en charge. Rev Mal Respir 2003; 20: 4S56-64.
3. Seemungal T.A.R., Donaldson G.C., Bhowmik A., Jeffries D.J., and Wedzicha J.A. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161 (2000) 1608-1613
4. Celli B.R., MacNee W., Agusti A., Anzueto A., Berg B., Buist A.S., et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
5. GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2008. www.goldcopd.com.
6. Chabot F., Devillier P., Drugeon H., Dusser D., Fournier M., Gaillat J., et al. Prévention des exacerbations dans la BPCO. Réflexion sur la construction d'une étude clinique évaluant l'effet des corticostéroïdes inhales. Rev Mal Respir 21 (2004) 685-688
7. O'Donnell D., Aaron S., Bourbeau J., Hernandez P., Marciniuk D.D., Batter M., et al. Recommandations de la Société canadienne de thoracologie au sujet de la prise en charge de la maladie pulmonaire obstructive chronique. Mise à jour de 2007. Can Respir J 14 (2007) 5-32B
8. Quon B.S., Gan W.Q., and Sin D.D. Contemporary management of acute exacerbations of COPD : a systematic review and metaanalysis. Chest 133 (2008) 756-766
9. Donaldson G.C., Seemungal T.A.R., Bhowmik A., and Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57 (2002) 847-852
10. Connors Jr. A.F., Dawson N.V., Thomas C., Harrell Jr. F.E., Desbiens N., Fulkerson W.J., et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease: the SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 154 (1996) 959-967
11. Seneff M.G., Wagner D.P., Wagner R.P., Zimmerman J.E., and Knaus W.A. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 274 (1995) 1852-1857
12. Berkius J., Nolin T., Mardh C., Karlström G., Walther S.M., and on behalf of the Swedish intensive care registry. Characteristics and long-term outcome of acute exacerbations in chronic obstructive pulmonary disease : an analysis of cases in the Swedish Intensive Care Registry during 2002-6. Acta Anesthesiol Scand 52 (2008) 759-765
13. Soler-Cataluna J.J., Marti{dotless}nez-Garci{dotless}a M.A., Roman Sanchez P., Salcedo E., Navarro M., and Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60 (2005) 925-931
14. Gunen H., Hacievliyagil S.S., Kosar F., Mutlu L.C., Gulbas G., Pehlivan E., et al. Factors affecting survival of hospitalised patients with COPD. Eur Respir J 26 (2005) 234-241
15. Wedzicha J.A., and Seemungal T.A.R. COPD exacerbations: defining their cause and prevention. Lancet 370 (2007) 786-796
16. Sykes A., Mallia P., and Johnston S.L. Diagnosis of pathogens in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4 (2007) 642-646
17. Papi A., Bellettato C.M., Braccioni F., Romagnoli M., Casolari P., Caramori G., et al. Am J Respir Crit Care Med 173 (2006) 114-121
18. Sehti S., and Murphy T.F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 359 (2008) 2355-2365
19. Seemungal T., Harper-Owen R., Bhowmik A., Moric I., Sanderson G., Message S., et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 1168-1223
20. Barbera J.A., Roca J., Ferrer A., Felez M.A., Diaz O., Roger N., et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 10 (1997) 1285-1291
21. Wouters E.F.M., Groenewegen K.H., Dentener M.A., and Vernooy J.H.J. Systemic inflammation in chronic obstructive pulmonary disease : the role of exacerbations. Proc Am Thor Soc 4 (2007) 626-634
22. Makris D., Moschandreas J., Damianaki A., Ntaoukakis E., Siafakas N.M., Milic Emili J., et al. Exacerbations and lung function decline in COPD: New insights in current and ex-smokers. Respiratory Medicine 101 (2007) 1305-1312
23. Miravitlles M., Ferrer M., Pont A., Zalacain R., Alvarez-Sala J.L., Masa F., et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 59 (2004) 387-395
24. Makris D., Tzanakis N., Damianaki A., Ntaoukakis E., Neofytou E., Zervou M., et al. Microsatellite DNA instability and COPD exacerbations. Eur Respir J 32 (2008) 612-618
25. Chabot F., Kheir A., Boyer L., and Gomez E. Insuffisance respiratoire aiguë au cours des BPCO. In: Chabot F., Maître B., and Marquette C.H. (Eds). Urgences respiratoires (2006), Da Tebe, Paris 230-239
26. Thompson W.H., Nielson C.P., Carvalho P., Charan N.B., and Crowley J.J. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 154 (1996) 407-412
27. Davies L., Angus R.M., and Calverley P.M. Oral corticosteroids inpatients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 354 (1999) 456-460
28. Prise en charge des infections des voies respiratoires basses de l'adulte immunocompétent. 15° conférence de consensus en thérapeutique anti-infectieuse. Médecine Maladies infectieuses 2006; 5:41-51.
29. Nici L., Donner C., Wouters E., Zuwallack R., Ambrosino N., Bourbeau J., et al. American Thoracic Society/European Respiratory Society. Statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173 (2006) 1390-1413
30. Schols A.M.W.J., Slangen J., Volovics L., and Wouters E.F.M. Weigt loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1791-1797
31. 2 égale ou supérieure à 70 mmHg) chez les pulmonaires chroniques. In : Entretiens de Physio-pathologie respiratoire. Bull Physiopath Respir 1965; I: 335-44.
32. Ram FS, Picot J, Lightowler J, Wedzicha JA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004:CD004104.
33. Conférence de Consensus commune. Ventilation non invasive au cours de l'insuffisance respiratoire aiguë (nouveau-né exclu)-12 Octobre 2006-Paris. Paris : Elsevier-Masson ;2006. 140 p.
34. Chabot F., Cornette A., Robert V., Vial B., and Polu J.M. La ventilation à domicile après un séjour en réanimation. Rev Mal Respir 18 (2001) 267-282
35. Perrin C., Julien V., and Lemoigne F. Aspects pratiques et techniques de la ventilation non invasive. Rev Mal Respir 21 (2004) 556-566
36. Confalonieri M., Garuti G., Cattaruzza M.S., Osborn J.F., Antonelli M., Conti G., et al. A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. Eur Respir J 25 (2005) 348-355
37. Wongsurakiat P., Maranetra K.N., Wasi C., Kositanont U., Dejsomritrutai W., and Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: A randomized controlled study. Chest 125 (2004) 2011-2020
38. Alfageme I., Vazquez R., Reyes N., Munoz J., Fernandez A., Hernandez M., et al. Clinical efficacy of antipneumococcal vaccination in patients with COPD. Thorax 61 (2006) 189-195
39. Calverley P.M.A., Anderson J.A., Celli B., Ferguson G.T., Jenkins C., Jones P.W., et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356 (2007) 775-789
40. Tashkin D.P., Celli B., Seen S., Burkhart D., Kesten S., Mengoje S., et al., For the UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359 (2008) 1543-1554
41. Wedzicha J.A., Calverley P.M.A., Seemungal T.A., Hagan G., Ansari Z., Stockley R.A., and for the INSPIRE Investigators. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 177 (2008) 19-26
42. Aaron S.D., Vandemheen K.L., Fergusson D., Maltais F., Bourbeau J., Goldstein R., et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: A randomized trial. Ann Intern Med 146 (2007) 545-555
43. Seemungal T.A.R., Wilkinson T.M.A., Hurst J.R., Perera W.R., Sapsford R.J., and Wedzicha J.A. Long term erythromycin therapy is associated with decreased COPD exacerbations. Am J Respir Crit Care Med 178 (2008) 1139-1147
44. Zheng J.P., Kang J., Huang S.G., Chen P., Yao W.Z., Yang L., et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study) : a randomised placebo-controlled study. Lancet 371 (2008) 2013-2018
45. Soyseth V., Brekke P.H., Smith P., and Omland T. Statin use is associated with reduced mortality in COPD. Eur Respir J 29 (2007) 279-283